Literature DB >> 29624861

Proteinuria and risk of stroke in patients with hypertension: The Kailuan cohort study.

Anxin Wang1,2,3,4,5,6, Liye Dai1, Zhaoping Su1,2,3,4, Shuohua Chen7, Junjuan Li8, Shouling Wu7, Yongjun Wang1,2,3,4, Yilong Wang1,2,3,4.   

Abstract

Proteinuria is associated with stroke, but the effects of changes in proteinuria on stroke risk are not well understood in the hypertensive population. This study examined whether proteinuria changes across 2-year assessments were associated with incident stroke in individuals with hypertension. We used visit data from 24 300 participants with hypertension of the Kailuan study who were stroke free at baseline. Based on the baseline and 2-year dipstick screening results, participants were classified as having no, remittent, incident, or persistent proteinuria. The relationship between proteinuria and stroke was analyzed using Cox proportional-hazards models after adjusting for potential variables. During a median of 6.89-year follow-up, we identified 1197 people with stroke. Compared to those with no proteinuria, stroke risk was significantly increased in participants with incident (hazard ratio [HR] 1.41, 95% CI, 1.05-1.77) and persistent proteinuria (HR 1.49, 95% CI, 1.25-1.89) after adjustment for other factors, which was consistent in ischemic stroke and intracerebral hemorrhage. No interaction was found between changes of proteinuria and diabetes mellitus in the hypertensive population. Changes in proteinuria exposure, particularly persistent proteinuria, play a role in reflecting the risk of stroke in patients with hypertension. ©2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  chronic kidney disease; hypertension; proteinuria; stroke

Mesh:

Year:  2018        PMID: 29624861      PMCID: PMC8031051          DOI: 10.1111/jch.13255

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  31 in total

Review 1.  Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward.

Authors:  Adeera Levin; Paul E Stevens
Journal:  Kidney Int       Date:  2013-11-27       Impact factor: 10.612

2.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

3.  Prevalence of Chronic Kidney Disease in Adults with Type 2 Diabetes Mellitus.

Authors:  Serena K M Low; Chee Fang Sum; Lee Ying Yeoh; Subramaniam Tavintharan; Xiao Wei Ng; Simon B M Lee; Wern E E Tang; Su Chi Lim
Journal:  Ann Acad Med Singapore       Date:  2015-05       Impact factor: 2.473

Review 4.  Microalbuminuria as a risk predictor in diabetes: the continuing saga.

Authors:  George L Bakris; Mark Molitch
Journal:  Diabetes Care       Date:  2014       Impact factor: 19.112

5.  Prevalence, awareness, treatment, and control of hypertension in rural China: results from Shandong Province.

Authors:  Hui Li; Qingyue Meng; Xiaoyun Sun; Amy Salter; Nancy E Briggs; Janet E Hiller
Journal:  J Hypertens       Date:  2010-03       Impact factor: 4.844

Review 6.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

7.  Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach.

Authors:  Giovanna Leoncini; Giorgio Sacchi; Francesca Viazzi; Maura Ravera; Denise Parodi; Elena Ratto; Simone Vettoretti; Cinzia Tomolillo; Giacomo Deferrari; Roberto Pontremoli
Journal:  J Hypertens       Date:  2002-07       Impact factor: 4.844

8.  Association of kidney disease measures with ischemic versus hemorrhagic strokes: pooled analyses of 4 prospective community-based cohorts.

Authors:  Bakhtawar K Mahmoodi; Hiroshi Yatsuya; Kunihiro Matsushita; Yinying Sang; Rebecca F Gottesman; Brad C Astor; Mark Woodward; W T Longstreth; Bruce M Psaty; Michael G Shlipak; Aaron R Folsom; Ron T Gansevoort; Josef Coresh
Journal:  Stroke       Date:  2014-05-29       Impact factor: 7.914

9.  Proteinuria and risk of stroke in patients with hypertension: The Kailuan cohort study.

Authors:  Anxin Wang; Liye Dai; Zhaoping Su; Shuohua Chen; Junjuan Li; Shouling Wu; Yongjun Wang; Yilong Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-06       Impact factor: 3.738

10.  Cumulative Exposure to Ideal Cardiovascular Health and Incident Diabetes in a Chinese Population: The Kailuan Study.

Authors:  Xiaoxue Liu; Liufu Cui; Anxin Wang; Xizhu Wang; Qiaofeng Song; Shanshan Li; Jihong Shi; Xiaohong Zhao; Shuohua Chen; Xin Du; Chunpeng Ji; Rachel Huxley; Yuming Guo; Shouling Wu
Journal:  J Am Heart Assoc       Date:  2016-09-16       Impact factor: 5.501

View more
  2 in total

1.  Proteinuria and risk of stroke in patients with hypertension: The Kailuan cohort study.

Authors:  Anxin Wang; Liye Dai; Zhaoping Su; Shuohua Chen; Junjuan Li; Shouling Wu; Yongjun Wang; Yilong Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-06       Impact factor: 3.738

2.  Visit-to-Visit Variability of Lipids Measurements and the Risk of Stroke and Stroke Types: A Prospective Cohort Study.

Authors:  Anxin Wang; Haibin Li; Jinhuan Yuan; Yingting Zuo; Yijun Zhang; Shouhua Chen; Shouling Wu; Yongjun Wang
Journal:  J Stroke       Date:  2020-01-31       Impact factor: 6.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.